Sign In
Buy EW
$86.00
-1.66 (-1.89%)
At Close: Jun 03, 2026
Edwards (EW) Gains From RESILIA's Global Adoption, TAVR Growth
10:45am, Wednesday, 06'th Mar 2024
With the Critical Care spin-off, Edwards (EW) is looking to pursue growth in TAVR, TMTT and Surgical, as well as new investments in interventional heart failure technologies.
HOLX or EW: Which Is the Better Value Stock Right Now?
12:41pm, Tuesday, 27'th Feb 2024
Investors interested in Medical - Instruments stocks are likely familiar with Hologic (HOLX) and Edwards Lifesciences (EW). But which of these two stocks offers value investors a better bang for their
These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your Radar
09:51am, Tuesday, 27'th Feb 2024
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Here's Why You Should Buy Edward Lifesciences (EW) Stock Now
12:56pm, Monday, 26'th Feb 2024
Investors are optimistic about Edward Lifesciences' (EW) progress with the Structural Heart business and strong TAVR potential.
Edwards Lifesciences to Present at the 44th Annual TD Cowen Healthcare Conference
07:05am, Friday, 23'rd Feb 2024
IRVINE, Calif.--(BUSINESS WIRE)--Edwards Lifesciences Corporation (NYSE: EW) today announced it will participate in the TD Cowen Healthcare Conference on Tuesday, March 5, 2024. Bernard Zovighian, chi
Edwards (EW) Gains From Balanced Core Growth and New Launches
10:40am, Thursday, 15'th Feb 2024
Edwards (EW) is demonstrating the strong performance of the SAPIEN 3 Ultra valve in the United States, Europe and Rest of World.
3 Medtech Stocks Likely to Top Estimates This Earnings Season
08:51am, Tuesday, 13'th Feb 2024
Here are three stocks, GMED, GKOS and PRCT, which are expected to beat earnings estimates in the ongoing reporting cycle.
Edwards Lifesciences (EW) Q4 Earnings Meet, Margins Dip
11:36am, Wednesday, 07'th Feb 2024
Edwards Lifesciences' (EW) Q4 revenues register year-over-year growth on its strong differentiated portfolio of advanced therapies.
Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript
09:05pm, Tuesday, 06'th Feb 2024
Edwards Lifesciences Corporation (EW) Q4 2023 Earnings Call Transcript
Compared to Estimates, Edwards Lifesciences (EW) Q4 Earnings: A Look at Key Metrics
07:01pm, Tuesday, 06'th Feb 2024
Although the revenue and EPS for Edwards Lifesciences (EW) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare wit
Edwards Lifesciences (EW) Q4 Earnings Match Estimates
06:26pm, Tuesday, 06'th Feb 2024
Edwards Lifesciences (EW) came out with quarterly earnings of $0.64 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.64 per share a year ago.
Edwards Lifesciences beats quarterly estimates on strong heart device sales
05:43pm, Tuesday, 06'th Feb 2024
Edwards Lifesciences reported fourth-quarter profit on Tuesday that beat Wall Street estimates, helped by strong demand for the company's artificial heart valves and other devices.
Edwards Lifesciences (EW) Wins FDA Nod for the EVOQUE System
08:21am, Tuesday, 06'th Feb 2024
Edwards Lifesciences' (EW) EVOQUE valve replacement system becomes the first transcatheter therapy to earn FDA approval for a tricuspid valve.
ITGR or EW: Which Is the Better Value Stock Right Now?
12:41pm, Monday, 05'th Feb 2024
Investors looking for stocks in the Medical - Instruments sector might want to consider either Integer (ITGR) or Edwards Lifesciences (EW). But which of these two companies is the best option for thos
Stay Ahead of the Game With Edwards Lifesciences (EW) Q4 Earnings: Wall Street's Insights on Key Metrics
10:21am, Thursday, 01'st Feb 2024
Beyond analysts' top -and-bottom-line estimates for Edwards Lifesciences (EW), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for
